{
  "metadata": {
    "graph_path": "./logic_graph.png",
    "num_solutions": 6,
    "family_stats": {
      "1": {
        "core": 1,
        "branch": 0
      },
      "2": {
        "core": 1,
        "branch": 1
      },
      "3": {
        "core": 1,
        "branch": 0
      },
      "4": {
        "core": 1,
        "branch": 0
      },
      "5": {
        "core": 1,
        "branch": 0
      }
    }
  },
  "knowledge_base": {
    "rules": [
      {
        "id": "Rule1",
        "formal": "(A1 → G)",
        "prover9_expression": "(receives_funding(Facility, GovernmentGrant) -> achieves(Research, Breakthrough))",
        "natural": "If the research facility receives government grant funding, then the research achieves a breakthrough"
      },
      {
        "id": "Rule2",
        "formal": "(A11 → A12)",
        "prover9_expression": "(submits(Organization, ClinicalTrialApplication) -> completes(Organization, PreClinicalTesting))",
        "natural": "If the organization submits a clinical trial application, then the organization completes pre-clinical testing"
      },
      {
        "id": "Rule3",
        "formal": "(A12 → A10)",
        "prover9_expression": "(completes(Organization, PreClinicalTesting) -> approved(ClinicalTrial, RegulatoryBody))",
        "natural": "If the organization completes pre-clinical testing, then the clinical trial receives regulatory body approval"
      },
      {
        "id": "Rule4",
        "formal": "(A14 → A15)",
        "prover9_expression": "(develops(Organization, AlternativeCompound) -> identifies(Researchers, SideEffects))",
        "natural": "If the organization develops an alternative compound, then researchers identify side effects"
      },
      {
        "id": "Rule5",
        "formal": "(A15 → A17)",
        "prover9_expression": "(identifies(Researchers, SideEffects) -> observes(Researchers, AdverseReactions))",
        "natural": "If researchers identify side effects, then researchers observe adverse reactions"
      },
      {
        "id": "Rule6",
        "formal": "(A15 → ¬A16)",
        "prover9_expression": "(identifies(Researchers, SideEffects) -> -modifies(Researchers, DrugFormulation))",
        "natural": "If researchers identify side effects, then researchers do not modify the drug formulation"
      },
      {
        "id": "Rule7",
        "formal": "(A17 → A16)",
        "prover9_expression": "(observes(Researchers, AdverseReactions) -> modifies(Researchers, DrugFormulation))",
        "natural": "If researchers observe adverse reactions, then researchers modify the drug formulation"
      },
      {
        "id": "Rule8",
        "formal": "(A18 ∨ G)",
        "prover9_expression": "(achieves(Platform, CommercialSuccess) | achieves(Research, Breakthrough))",
        "natural": "The platform achieves commercial success or the research achieves a breakthrough"
      },
      {
        "id": "Rule9",
        "formal": "(A19 → ¬A18)",
        "prover9_expression": "(faces(Platform, MarketCompetition) -> -achieves(Platform, CommercialSuccess))",
        "natural": "If the platform faces market competition, then the platform does not achieve commercial success"
      },
      {
        "id": "Rule10",
        "formal": "(A2 → G)",
        "prover9_expression": "(receives_funding(Facility, CorporateGrant) -> achieves(Research, Breakthrough))",
        "natural": "If the research facility receives corporate grant funding, then the research achieves a breakthrough"
      },
      {
        "id": "Rule11",
        "formal": "(A20 → A19)",
        "prover9_expression": "(invests(Company, MarketingCampaign) -> faces(Platform, MarketCompetition))",
        "natural": "If the company invests in a marketing campaign, then the platform faces market competition"
      },
      {
        "id": "Rule12",
        "formal": "(A22 ∨ A23)",
        "prover9_expression": "(implements(Company, PriceReduction) | launches(Company, PromotionalOffer))",
        "natural": "The company implements a price reduction or the company launches a promotional offer"
      },
      {
        "id": "Rule13",
        "formal": "(A23 → (¬A20 → A21))",
        "prover9_expression": "(launches(Company, PromotionalOffer) -> (-invests(Company, MarketingCampaign) -> gains(Platform, MarketShare)))",
        "natural": "If the company launches a promotional offer, then under the condition that the company does not invest in a marketing campaign, the platform gains market share"
      },
      {
        "id": "Rule14",
        "formal": "(A24 → (A22 → (¬A20 → A21)))",
        "prover9_expression": "(analyzes(Company, MarketData) -> (implements(Company, PriceReduction) -> (-invests(Company, MarketingCampaign) -> gains(Platform, MarketShare))))",
        "natural": "If the company analyzes market data, then should the company implement a price reduction, given that the company does not invest in a marketing campaign, the platform gains market share"
      },
      {
        "id": "Rule15",
        "formal": "(A24 ∨ A25)",
        "prover9_expression": "(analyzes(Company, MarketData) | conducts(Company, ConsumerSurvey))",
        "natural": "The company analyzes market data or the company conducts a consumer survey"
      },
      {
        "id": "Rule16",
        "formal": "(A25 → (A22 → (¬A20 → A21)))",
        "prover9_expression": "(conducts(Company, ConsumerSurvey) -> (implements(Company, PriceReduction) -> (-invests(Company, MarketingCampaign) -> gains(Platform, MarketShare))))",
        "natural": "If the company conducts a consumer survey, then whenever the company implements a price reduction and the company does not invest in a marketing campaign, the platform gains market share"
      },
      {
        "id": "Rule17",
        "formal": "(A26 → A27)",
        "prover9_expression": "(contains(Material, Alcohol) -> requires(Material, SpecialStorage))",
        "natural": "If the material contains alcohol, then the material requires special storage"
      },
      {
        "id": "Rule18",
        "formal": "(A26 ∨ G)",
        "prover9_expression": "(contains(Material, Alcohol) | achieves(Research, Breakthrough))",
        "natural": "The material contains alcohol or the research achieves a breakthrough"
      },
      {
        "id": "Rule19",
        "formal": "(A28 ∨ ¬A27)",
        "prover9_expression": "(degrades(Material, RoomTemperature) | -requires(Material, SpecialStorage))",
        "natural": "The material degrades at room temperature or the material does not require special storage"
      },
      {
        "id": "Rule20",
        "formal": "(A3 → A1)",
        "prover9_expression": "(conducts_research(Facility, PlantExtract) -> receives_funding(Facility, GovernmentGrant))",
        "natural": "If the research facility conducts research on plant extracts, then the research facility receives government grant funding"
      },
      {
        "id": "Rule21",
        "formal": "(A4 → A2)",
        "prover9_expression": "(conducts_research(Facility, SyntheticCompound) -> receives_funding(Facility, CorporateGrant))",
        "natural": "If the research facility conducts research on synthetic compounds, then the research facility receives corporate grant funding"
      },
      {
        "id": "Rule22",
        "formal": "(A5 → ¬A6)",
        "prover9_expression": "(synthesizes(Facility, PlantExtract, DrugCompound) -> -progresses(Research, PlantExtract))",
        "natural": "If the research facility synthesizes plant extracts into drug compounds, then research on plant extracts does not progress"
      },
      {
        "id": "Rule23",
        "formal": "(A5 ∨ (A3 ∨ A4))",
        "prover9_expression": "(synthesizes(Facility, PlantExtract, DrugCompound) | (conducts_research(Facility, PlantExtract) | conducts_research(Facility, SyntheticCompound)))",
        "natural": "The research facility synthesizes plant extracts into drug compounds or the research facility conducts research on plant extracts or the research facility conducts research on synthetic compounds"
      },
      {
        "id": "Rule24",
        "formal": "(A8 → G)",
        "prover9_expression": "(publishes(Organization, ResearchPaper) -> achieves(Research, Breakthrough))",
        "natural": "If the organization publishes a research paper, then the research achieves a breakthrough"
      },
      {
        "id": "Rule25",
        "formal": "(A8 ∨ A9)",
        "prover9_expression": "(publishes(Organization, ResearchPaper) | presents(Organization, ConferenceFindings))",
        "natural": "The organization publishes a research paper or the organization presents conference findings"
      },
      {
        "id": "Rule26",
        "formal": "(¬(A13 ∨ G) → A14)",
        "prover9_expression": "(-(receives(Platform, RegulatoryApproval) | achieves(Research, Breakthrough)) -> develops(Organization, AlternativeCompound))",
        "natural": "If neither the platform receives regulatory approval nor the research achieves a breakthrough, then the organization develops an alternative compound"
      },
      {
        "id": "Rule27",
        "formal": "(¬(A30 → A29) → A31)",
        "prover9_expression": "(-(files(Organization, PatentExtension) -> extends(Organization, PatentProtection)) -> challenged(Patent, GenericManufacturers))",
        "natural": "If it is not the case that filing a patent extension by the organization leads to extended patent protection, then the patent is challenged by generic manufacturers"
      },
      {
        "id": "Rule28",
        "formal": "(¬(A30 → A29) → ¬A31)",
        "prover9_expression": "(-(files(Organization, PatentExtension) -> extends(Organization, PatentProtection)) -> -challenged(Patent, GenericManufacturers))",
        "natural": "If it is not the case that filing a patent extension by the organization leads to extended patent protection, then the patent is not challenged by generic manufacturers"
      },
      {
        "id": "Rule29",
        "formal": "(¬(A5 → A6) → A7)",
        "prover9_expression": "(-(synthesizes(Facility, PlantExtract, DrugCompound) -> progresses(Research, PlantExtract)) -> designed(ManufacturingProcess, PlantExtract))",
        "natural": "If synthesizing plant extracts into drug compounds by the research facility does not result in progress of research on plant extracts, then a manufacturing process for plant extracts is designed"
      },
      {
        "id": "Rule30",
        "formal": "(¬(A5 → A6) → ¬A7)",
        "prover9_expression": "(-(synthesizes(Facility, PlantExtract, DrugCompound) -> progresses(Research, PlantExtract)) -> -designed(ManufacturingProcess, PlantExtract))",
        "natural": "If synthesizing plant extracts into drug compounds by the research facility does not result in progress of research on plant extracts, then a manufacturing process for plant extracts is not designed"
      },
      {
        "id": "Rule31",
        "formal": "(¬(A9 → G) → A11)",
        "prover9_expression": "(-(presents(Organization, ConferenceFindings) -> achieves(Research, Breakthrough)) -> submits(Organization, ClinicalTrialApplication))",
        "natural": "If presenting conference findings by the organization does not lead to research breakthrough, then the organization submits a clinical trial application"
      },
      {
        "id": "Rule32",
        "formal": "(¬(¬(A9 → G) → A10) → A30)",
        "prover9_expression": "(-(-(presents(Organization, ConferenceFindings) -> achieves(Research, Breakthrough)) -> approved(ClinicalTrial, RegulatoryBody)) -> files(Organization, PatentExtension))",
        "natural": "If the failure of presenting conference findings to lead to research breakthrough does not result in clinical trial approval by the regulatory body, then the organization files a patent extension"
      },
      {
        "id": "Rule33",
        "formal": "(¬(¬(A9 → G) → A10) → ¬A29)",
        "prover9_expression": "(-(-(presents(Organization, ConferenceFindings) -> achieves(Research, Breakthrough)) -> approved(ClinicalTrial, RegulatoryBody)) -> -extends(Organization, PatentProtection))",
        "natural": "If the failure of presenting conference findings to lead to research breakthrough does not result in clinical trial approval by the regulatory body, then the organization does not extend patent protection"
      }
    ],
    "facts": [
      {
        "id": "Fact1",
        "formal": "¬A10",
        "prover9_expression": "-approved(ClinicalTrial, RegulatoryBody)",
        "natural": "The clinical trial does not receive regulatory body approval"
      },
      {
        "id": "Fact2",
        "formal": "¬A13",
        "prover9_expression": "-receives(Platform, RegulatoryApproval)",
        "natural": "The platform does not receive regulatory approval"
      },
      {
        "id": "Fact3",
        "formal": "¬A21",
        "prover9_expression": "-gains(Platform, MarketShare)",
        "natural": "The platform does not gain market share"
      },
      {
        "id": "Fact4",
        "formal": "¬A28",
        "prover9_expression": "-degrades(Material, RoomTemperature)",
        "natural": "The material does not degrade at room temperature"
      }
    ]
  },
  "target": {
    "formal": "G",
    "prover9": "G",
    "prover9_expression": "achieves(Research, Breakthrough)",
    "natural": "The research achieves a breakthrough"
  },
  "solutions": [
    {
      "id": 1,
      "family_id": 1,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A5 -> A6) -> A7)",
            "(-(A5 -> A6) -> -A7)"
          ],
          "conclusion": "(A5 -> A6)",
          "natural": "If the research facility synthesizes plant extracts into drug compounds, then research on plant extracts progresses"
        },
        {
          "step_number": 2,
          "rule_applied": "RAA",
          "premises_used": [
            "(A5 -> A6)",
            "(A5 -> -A6)"
          ],
          "conclusion": "-A5",
          "natural": "The research facility does not synthesize plant extracts into drug compounds"
        },
        {
          "step_number": 3,
          "rule_applied": "DS",
          "premises_used": [
            "(A5 | (A3 | A4))",
            "-A5"
          ],
          "conclusion": "(A3 | A4)",
          "natural": "The research facility conducts research on plant extracts or the research facility conducts research on synthetic compounds"
        },
        {
          "step_number": 4,
          "rule_applied": "CD",
          "premises_used": [
            "(A3 -> A1)",
            "(A4 -> A2)",
            "(A3 | A4)"
          ],
          "conclusion": "(A1 | A2)",
          "natural": "The research facility receives government grant funding or the research facility receives corporate grant funding"
        },
        {
          "step_number": 5,
          "rule_applied": "DE",
          "premises_used": [
            "(A1 | A2)",
            "(A1 -> G)",
            "(A2 -> G)"
          ],
          "conclusion": "G",
          "natural": "The research achieves a breakthrough"
        }
      ]
    },
    {
      "id": 2,
      "family_id": 2,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(A11 -> A12)",
            "(A12 -> A10)"
          ],
          "conclusion": "(A11 -> A10)",
          "natural": "If the organization submits a clinical trial application, then the clinical trial receives regulatory body approval"
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            "(-(A9 -> G) -> A11)",
            "(A11 -> A10)"
          ],
          "conclusion": "(-(A9 -> G) -> A10)",
          "natural": "If presenting conference findings by the organization does not lead to research breakthrough, then the clinical trial receives regulatory body approval"
        },
        {
          "step_number": 3,
          "rule_applied": "MT",
          "premises_used": [
            "(-(A9 -> G) -> A10)",
            "-A10"
          ],
          "conclusion": "(A9 -> G)",
          "natural": "If the organization presents conference findings, then the research achieves a breakthrough"
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            "(A8 | A9)",
            "(A8 -> G)",
            "(A9 -> G)"
          ],
          "conclusion": "G",
          "natural": "The research achieves a breakthrough"
        }
      ]
    },
    {
      "id": 3,
      "family_id": 3,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(A15 -> A17)",
            "(A17 -> A16)"
          ],
          "conclusion": "(A15 -> A16)",
          "natural": "If researchers identify side effects, then researchers modify the drug formulation"
        },
        {
          "step_number": 2,
          "rule_applied": "RAA",
          "premises_used": [
            "(A15 -> A16)",
            "(A15 -> -A16)"
          ],
          "conclusion": "-A15",
          "natural": "Researchers do not identify side effects"
        },
        {
          "step_number": 3,
          "rule_applied": "MT",
          "premises_used": [
            "(A14 -> A15)",
            "-A15"
          ],
          "conclusion": "-A14",
          "natural": "The organization does not develop an alternative compound"
        },
        {
          "step_number": 4,
          "rule_applied": "MT",
          "premises_used": [
            "(-(A13 | G) -> A14)",
            "-A14"
          ],
          "conclusion": "(A13 | G)",
          "natural": "The platform receives regulatory approval or the research achieves a breakthrough"
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            "(A13 | G)",
            "-A13"
          ],
          "conclusion": "G",
          "natural": "The research achieves a breakthrough"
        }
      ]
    },
    {
      "id": 4,
      "family_id": 4,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DE",
          "premises_used": [
            "(A24 | A25)",
            "(A24 -> (A22 -> (-A20 -> A21)))",
            "(A25 -> (A22 -> (-A20 -> A21)))"
          ],
          "conclusion": "(A22 -> (-A20 -> A21))",
          "natural": "If the company implements a price reduction, then provided that the company does not invest in a marketing campaign, the platform gains market share"
        },
        {
          "step_number": 2,
          "rule_applied": "DE",
          "premises_used": [
            "(A22 | A23)",
            "(A22 -> (-A20 -> A21))",
            "(A23 -> (-A20 -> A21))"
          ],
          "conclusion": "(-A20 -> A21)",
          "natural": "If the company does not invest in a marketing campaign, then the platform gains market share"
        },
        {
          "step_number": 3,
          "rule_applied": "MT",
          "premises_used": [
            "(-A20 -> A21)",
            "-A21"
          ],
          "conclusion": "A20",
          "natural": "The company invests in a marketing campaign"
        },
        {
          "step_number": 4,
          "rule_applied": "MP",
          "premises_used": [
            "(A20 -> A19)",
            "A20"
          ],
          "conclusion": "A19",
          "natural": "The platform faces market competition"
        },
        {
          "step_number": 5,
          "rule_applied": "MP",
          "premises_used": [
            "(A19 -> -A18)",
            "A19"
          ],
          "conclusion": "-A18",
          "natural": "The platform does not achieve commercial success"
        },
        {
          "step_number": 6,
          "rule_applied": "DS",
          "premises_used": [
            "(A18 | G)",
            "-A18"
          ],
          "conclusion": "G",
          "natural": "The research achieves a breakthrough"
        }
      ]
    },
    {
      "id": 5,
      "family_id": 5,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DS",
          "premises_used": [
            "(A28 | -A27)",
            "-A28"
          ],
          "conclusion": "-A27",
          "natural": "The material does not require special storage"
        },
        {
          "step_number": 2,
          "rule_applied": "MT",
          "premises_used": [
            "(A26 -> A27)",
            "-A27"
          ],
          "conclusion": "-A26",
          "natural": "The material does not contain alcohol"
        },
        {
          "step_number": 3,
          "rule_applied": "DS",
          "premises_used": [
            "(A26 | G)",
            "-A26"
          ],
          "conclusion": "G",
          "natural": "The research achieves a breakthrough"
        }
      ]
    },
    {
      "id": 6,
      "family_id": 2,
      "path_type": "branch",
      "branch_from": 1,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A30 -> A29) -> A31)",
            "(-(A30 -> A29) -> -A31)"
          ],
          "conclusion": "(A30 -> A29)",
          "natural": "If the organization files a patent extension, then the organization extends patent protection"
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            "(-(-(A9 -> G) -> A10) -> A30)",
            "(A30 -> A29)"
          ],
          "conclusion": "(-(-(A9 -> G) -> A10) -> A29)",
          "natural": "If the failure of presenting conference findings to lead to research breakthrough does not result in clinical trial approval by the regulatory body, then the organization extends patent protection"
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(-(A9 -> G) -> A10) -> A29)",
            "(-(-(A9 -> G) -> A10) -> -A29)"
          ],
          "conclusion": "(-(A9 -> G) -> A10)",
          "natural": "If presenting conference findings by the organization does not lead to research breakthrough, then the clinical trial receives regulatory body approval"
        },
        {
          "step_number": 4,
          "rule_applied": "MT",
          "premises_used": [
            "(-(A9 -> G) -> A10)",
            "-A10"
          ],
          "conclusion": "(A9 -> G)",
          "natural": "If the organization presents conference findings, then the research achieves a breakthrough"
        },
        {
          "step_number": 5,
          "rule_applied": "DE",
          "premises_used": [
            "(A8 | A9)",
            "(A8 -> G)",
            "(A9 -> G)"
          ],
          "conclusion": "G",
          "natural": "The research achieves a breakthrough"
        }
      ]
    }
  ],
  "translations": {
    "atomic_facts": {
      "A1": "receives_funding(Facility, GovernmentGrant)",
      "A2": "receives_funding(Facility, CorporateGrant)",
      "A3": "conducts_research(Facility, PlantExtract)",
      "A4": "conducts_research(Facility, SyntheticCompound)",
      "A5": "synthesizes(Facility, PlantExtract, DrugCompound)",
      "A6": "progresses(Research, PlantExtract)",
      "A7": "designed(ManufacturingProcess, PlantExtract)",
      "A8": "publishes(Organization, ResearchPaper)",
      "A9": "presents(Organization, ConferenceFindings)",
      "A10": "approved(ClinicalTrial, RegulatoryBody)",
      "A11": "submits(Organization, ClinicalTrialApplication)",
      "A12": "completes(Organization, PreClinicalTesting)",
      "A13": "receives(Platform, RegulatoryApproval)",
      "A14": "develops(Organization, AlternativeCompound)",
      "A15": "identifies(Researchers, SideEffects)",
      "A16": "modifies(Researchers, DrugFormulation)",
      "A17": "observes(Researchers, AdverseReactions)",
      "A18": "achieves(Platform, CommercialSuccess)",
      "A19": "faces(Platform, MarketCompetition)",
      "A20": "invests(Company, MarketingCampaign)",
      "A21": "gains(Platform, MarketShare)",
      "A22": "implements(Company, PriceReduction)",
      "A23": "launches(Company, PromotionalOffer)",
      "A24": "analyzes(Company, MarketData)",
      "A25": "conducts(Company, ConsumerSurvey)",
      "A26": "contains(Material, Alcohol)",
      "A27": "requires(Material, SpecialStorage)",
      "A28": "degrades(Material, RoomTemperature)",
      "A29": "extends(Organization, PatentProtection)",
      "A30": "files(Organization, PatentExtension)",
      "A31": "challenged(Patent, GenericManufacturers)",
      "G": "achieves(Research, Breakthrough)"
    },
    "natural_facts": {
      "A1": "The research facility receives government grant funding",
      "A2": "The research facility receives corporate grant funding",
      "A3": "The research facility conducts research on plant extracts",
      "A4": "The research facility conducts research on synthetic compounds",
      "A5": "The research facility synthesizes plant extracts into drug compounds",
      "A6": "Research on plant extracts progresses",
      "A7": "A manufacturing process for plant extracts is designed",
      "A8": "The organization publishes a research paper",
      "A9": "The organization presents conference findings",
      "A10": "The clinical trial receives regulatory body approval",
      "A11": "The organization submits a clinical trial application",
      "A12": "The organization completes pre-clinical testing",
      "A13": "The platform receives regulatory approval",
      "A14": "The organization develops an alternative compound",
      "A15": "Researchers identify side effects",
      "A16": "Researchers modify the drug formulation",
      "A17": "Researchers observe adverse reactions",
      "A18": "The platform achieves commercial success",
      "A19": "The platform faces market competition",
      "A20": "The company invests in a marketing campaign",
      "A21": "The platform gains market share",
      "A22": "The company implements a price reduction",
      "A23": "The company launches a promotional offer",
      "A24": "The company analyzes market data",
      "A25": "The company conducts a consumer survey",
      "A26": "The material contains alcohol",
      "A27": "The material requires special storage",
      "A28": "The material degrades at room temperature",
      "A29": "The organization extends patent protection",
      "A30": "The organization files a patent extension",
      "A31": "The patent is challenged by generic manufacturers",
      "G": "The research achieves a breakthrough"
    },
    "prover9_expressions": [
      "(receives_funding(Facility, GovernmentGrant) → achieves(Research, Breakthrough))",
      "(receives_funding(Facility, GovernmentGrant) ∨ receives_funding(Facility, CorporateGrant))",
      "(submits(Organization, ClinicalTrialApplication) → approved(ClinicalTrial, RegulatoryBody))",
      "(submits(Organization, ClinicalTrialApplication) → completes(Organization, PreClinicalTesting))",
      "(completes(Organization, PreClinicalTesting) → approved(ClinicalTrial, RegulatoryBody))",
      "(receives(Platform, RegulatoryApproval) ∨ achieves(Research, Breakthrough))",
      "(develops(Organization, AlternativeCompound) → identifies(Researchers, SideEffects))",
      "(identifies(Researchers, SideEffects) → modifies(Researchers, DrugFormulation))",
      "(identifies(Researchers, SideEffects) → observes(Researchers, AdverseReactions))",
      "(identifies(Researchers, SideEffects) → ¬modifies(Researchers, DrugFormulation))",
      "(observes(Researchers, AdverseReactions) → modifies(Researchers, DrugFormulation))",
      "(achieves(Platform, CommercialSuccess) ∨ achieves(Research, Breakthrough))",
      "(faces(Platform, MarketCompetition) → ¬achieves(Platform, CommercialSuccess))",
      "(receives_funding(Facility, CorporateGrant) → achieves(Research, Breakthrough))",
      "(invests(Company, MarketingCampaign) → faces(Platform, MarketCompetition))",
      "(implements(Company, PriceReduction) → (¬invests(Company, MarketingCampaign) → gains(Platform, MarketShare)))",
      "(implements(Company, PriceReduction) ∨ launches(Company, PromotionalOffer))",
      "(launches(Company, PromotionalOffer) → (¬invests(Company, MarketingCampaign) → gains(Platform, MarketShare)))",
      "(analyzes(Company, MarketData) → (implements(Company, PriceReduction) → (¬invests(Company, MarketingCampaign) → gains(Platform, MarketShare))))",
      "(analyzes(Company, MarketData) ∨ conducts(Company, ConsumerSurvey))",
      "(conducts(Company, ConsumerSurvey) → (implements(Company, PriceReduction) → (¬invests(Company, MarketingCampaign) → gains(Platform, MarketShare))))",
      "(contains(Material, Alcohol) → requires(Material, SpecialStorage))",
      "(contains(Material, Alcohol) ∨ achieves(Research, Breakthrough))",
      "(degrades(Material, RoomTemperature) ∨ ¬requires(Material, SpecialStorage))",
      "(conducts_research(Facility, PlantExtract) → receives_funding(Facility, GovernmentGrant))",
      "(conducts_research(Facility, PlantExtract) ∨ conducts_research(Facility, SyntheticCompound))",
      "(files(Organization, PatentExtension) → extends(Organization, PatentProtection))",
      "(conducts_research(Facility, SyntheticCompound) → receives_funding(Facility, CorporateGrant))",
      "(synthesizes(Facility, PlantExtract, DrugCompound) → progresses(Research, PlantExtract))",
      "(synthesizes(Facility, PlantExtract, DrugCompound) → ¬progresses(Research, PlantExtract))",
      "(synthesizes(Facility, PlantExtract, DrugCompound) ∨ (conducts_research(Facility, PlantExtract) ∨ conducts_research(Facility, SyntheticCompound)))",
      "(publishes(Organization, ResearchPaper) → achieves(Research, Breakthrough))",
      "(publishes(Organization, ResearchPaper) ∨ presents(Organization, ConferenceFindings))",
      "(presents(Organization, ConferenceFindings) → achieves(Research, Breakthrough))",
      "(¬(receives(Platform, RegulatoryApproval) ∨ achieves(Research, Breakthrough)) → develops(Organization, AlternativeCompound))",
      "(¬(files(Organization, PatentExtension) → extends(Organization, PatentProtection)) → challenged(Patent, GenericManufacturers))",
      "(¬(files(Organization, PatentExtension) → extends(Organization, PatentProtection)) → ¬challenged(Patent, GenericManufacturers))",
      "(¬(synthesizes(Facility, PlantExtract, DrugCompound) → progresses(Research, PlantExtract)) → designed(ManufacturingProcess, PlantExtract))",
      "(¬(synthesizes(Facility, PlantExtract, DrugCompound) → progresses(Research, PlantExtract)) → ¬designed(ManufacturingProcess, PlantExtract))",
      "(¬(presents(Organization, ConferenceFindings) → achieves(Research, Breakthrough)) → approved(ClinicalTrial, RegulatoryBody))",
      "(¬(presents(Organization, ConferenceFindings) → achieves(Research, Breakthrough)) → submits(Organization, ClinicalTrialApplication))",
      "(¬(¬(presents(Organization, ConferenceFindings) → achieves(Research, Breakthrough)) → approved(ClinicalTrial, RegulatoryBody)) → extends(Organization, PatentProtection))",
      "(¬(¬(presents(Organization, ConferenceFindings) → achieves(Research, Breakthrough)) → approved(ClinicalTrial, RegulatoryBody)) → files(Organization, PatentExtension))",
      "(¬(¬(presents(Organization, ConferenceFindings) → achieves(Research, Breakthrough)) → approved(ClinicalTrial, RegulatoryBody)) → ¬extends(Organization, PatentProtection))",
      "(¬invests(Company, MarketingCampaign) → gains(Platform, MarketShare))",
      "faces(Platform, MarketCompetition)",
      "invests(Company, MarketingCampaign)",
      "achieves(Research, Breakthrough)",
      "¬approved(ClinicalTrial, RegulatoryBody)",
      "¬receives(Platform, RegulatoryApproval)",
      "¬develops(Organization, AlternativeCompound)",
      "¬identifies(Researchers, SideEffects)",
      "¬achieves(Platform, CommercialSuccess)",
      "¬gains(Platform, MarketShare)",
      "¬contains(Material, Alcohol)",
      "¬requires(Material, SpecialStorage)",
      "¬degrades(Material, RoomTemperature)",
      "¬synthesizes(Facility, PlantExtract, DrugCompound)"
    ],
    "natural_expressions": [
      "If the research facility receives government grant funding, then the research achieves a breakthrough",
      "The research facility receives government grant funding or the research facility receives corporate grant funding",
      "If the organization submits a clinical trial application, then the clinical trial receives regulatory body approval",
      "If the organization submits a clinical trial application, then the organization completes pre-clinical testing",
      "If the organization completes pre-clinical testing, then the clinical trial receives regulatory body approval",
      "The platform receives regulatory approval or the research achieves a breakthrough",
      "If the organization develops an alternative compound, then researchers identify side effects",
      "If researchers identify side effects, then researchers modify the drug formulation",
      "If researchers identify side effects, then researchers observe adverse reactions",
      "If researchers identify side effects, then researchers do not modify the drug formulation",
      "If researchers observe adverse reactions, then researchers modify the drug formulation",
      "The platform achieves commercial success or the research achieves a breakthrough",
      "If the platform faces market competition, then the platform does not achieve commercial success",
      "If the research facility receives corporate grant funding, then the research achieves a breakthrough",
      "If the company invests in a marketing campaign, then the platform faces market competition",
      "If the company implements a price reduction, then provided that the company does not invest in a marketing campaign, the platform gains market share",
      "The company implements a price reduction or the company launches a promotional offer",
      "If the company launches a promotional offer, then under the condition that the company does not invest in a marketing campaign, the platform gains market share",
      "If the company analyzes market data, then should the company implement a price reduction, given that the company does not invest in a marketing campaign, the platform gains market share",
      "The company analyzes market data or the company conducts a consumer survey",
      "If the company conducts a consumer survey, then whenever the company implements a price reduction and the company does not invest in a marketing campaign, the platform gains market share",
      "If the material contains alcohol, then the material requires special storage",
      "The material contains alcohol or the research achieves a breakthrough",
      "The material degrades at room temperature or the material does not require special storage",
      "If the research facility conducts research on plant extracts, then the research facility receives government grant funding",
      "The research facility conducts research on plant extracts or the research facility conducts research on synthetic compounds",
      "If the organization files a patent extension, then the organization extends patent protection",
      "If the research facility conducts research on synthetic compounds, then the research facility receives corporate grant funding",
      "If the research facility synthesizes plant extracts into drug compounds, then research on plant extracts progresses",
      "If the research facility synthesizes plant extracts into drug compounds, then research on plant extracts does not progress",
      "The research facility synthesizes plant extracts into drug compounds or the research facility conducts research on plant extracts or the research facility conducts research on synthetic compounds",
      "If the organization publishes a research paper, then the research achieves a breakthrough",
      "The organization publishes a research paper or the organization presents conference findings",
      "If the organization presents conference findings, then the research achieves a breakthrough",
      "If neither the platform receives regulatory approval nor the research achieves a breakthrough, then the organization develops an alternative compound",
      "If it is not the case that filing a patent extension by the organization leads to extended patent protection, then the patent is challenged by generic manufacturers",
      "If it is not the case that filing a patent extension by the organization leads to extended patent protection, then the patent is not challenged by generic manufacturers",
      "If synthesizing plant extracts into drug compounds by the research facility does not result in progress of research on plant extracts, then a manufacturing process for plant extracts is designed",
      "If synthesizing plant extracts into drug compounds by the research facility does not result in progress of research on plant extracts, then a manufacturing process for plant extracts is not designed",
      "If presenting conference findings by the organization does not lead to research breakthrough, then the clinical trial receives regulatory body approval",
      "If presenting conference findings by the organization does not lead to research breakthrough, then the organization submits a clinical trial application",
      "If the failure of presenting conference findings to lead to research breakthrough does not result in clinical trial approval by the regulatory body, then the organization extends patent protection",
      "If the failure of presenting conference findings to lead to research breakthrough does not result in clinical trial approval by the regulatory body, then the organization files a patent extension",
      "If the failure of presenting conference findings to lead to research breakthrough does not result in clinical trial approval by the regulatory body, then the organization does not extend patent protection",
      "If the company does not invest in a marketing campaign, then the platform gains market share",
      "The platform faces market competition",
      "The company invests in a marketing campaign",
      "The research achieves a breakthrough",
      "The clinical trial does not receive regulatory body approval",
      "The platform does not receive regulatory approval",
      "The organization does not develop an alternative compound",
      "Researchers do not identify side effects",
      "The platform does not achieve commercial success",
      "The platform does not gain market share",
      "The material does not contain alcohol",
      "The material does not require special storage",
      "The material does not degrade at room temperature",
      "The research facility does not synthesize plant extracts into drug compounds"
    ],
    "node_mappings": {
      "(A1 → G)": {
        "formal": "(A1 → G)",
        "prover9": "(A1 -> G)",
        "prover9_expression": "(receives_funding(Facility, GovernmentGrant) -> achieves(Research, Breakthrough))",
        "natural": "If the research facility receives government grant funding, then the research achieves a breakthrough"
      },
      "(A1 ∨ A2)": {
        "formal": "(A1 ∨ A2)",
        "prover9": "(A1 | A2)",
        "prover9_expression": "(receives_funding(Facility, GovernmentGrant) | receives_funding(Facility, CorporateGrant))",
        "natural": "The research facility receives government grant funding or the research facility receives corporate grant funding"
      },
      "(A11 → A10)": {
        "formal": "(A11 → A10)",
        "prover9": "(A11 -> A10)",
        "prover9_expression": "(submits(Organization, ClinicalTrialApplication) -> approved(ClinicalTrial, RegulatoryBody))",
        "natural": "If the organization submits a clinical trial application, then the clinical trial receives regulatory body approval"
      },
      "(A11 → A12)": {
        "formal": "(A11 → A12)",
        "prover9": "(A11 -> A12)",
        "prover9_expression": "(submits(Organization, ClinicalTrialApplication) -> completes(Organization, PreClinicalTesting))",
        "natural": "If the organization submits a clinical trial application, then the organization completes pre-clinical testing"
      },
      "(A12 → A10)": {
        "formal": "(A12 → A10)",
        "prover9": "(A12 -> A10)",
        "prover9_expression": "(completes(Organization, PreClinicalTesting) -> approved(ClinicalTrial, RegulatoryBody))",
        "natural": "If the organization completes pre-clinical testing, then the clinical trial receives regulatory body approval"
      },
      "(A13 ∨ G)": {
        "formal": "(A13 ∨ G)",
        "prover9": "(A13 | G)",
        "prover9_expression": "(receives(Platform, RegulatoryApproval) | achieves(Research, Breakthrough))",
        "natural": "The platform receives regulatory approval or the research achieves a breakthrough"
      },
      "(A14 → A15)": {
        "formal": "(A14 → A15)",
        "prover9": "(A14 -> A15)",
        "prover9_expression": "(develops(Organization, AlternativeCompound) -> identifies(Researchers, SideEffects))",
        "natural": "If the organization develops an alternative compound, then researchers identify side effects"
      },
      "(A15 → A16)": {
        "formal": "(A15 → A16)",
        "prover9": "(A15 -> A16)",
        "prover9_expression": "(identifies(Researchers, SideEffects) -> modifies(Researchers, DrugFormulation))",
        "natural": "If researchers identify side effects, then researchers modify the drug formulation"
      },
      "(A15 → A17)": {
        "formal": "(A15 → A17)",
        "prover9": "(A15 -> A17)",
        "prover9_expression": "(identifies(Researchers, SideEffects) -> observes(Researchers, AdverseReactions))",
        "natural": "If researchers identify side effects, then researchers observe adverse reactions"
      },
      "(A15 → ¬A16)": {
        "formal": "(A15 → ¬A16)",
        "prover9": "(A15 -> -A16)",
        "prover9_expression": "(identifies(Researchers, SideEffects) -> -modifies(Researchers, DrugFormulation))",
        "natural": "If researchers identify side effects, then researchers do not modify the drug formulation"
      },
      "(A17 → A16)": {
        "formal": "(A17 → A16)",
        "prover9": "(A17 -> A16)",
        "prover9_expression": "(observes(Researchers, AdverseReactions) -> modifies(Researchers, DrugFormulation))",
        "natural": "If researchers observe adverse reactions, then researchers modify the drug formulation"
      },
      "(A18 ∨ G)": {
        "formal": "(A18 ∨ G)",
        "prover9": "(A18 | G)",
        "prover9_expression": "(achieves(Platform, CommercialSuccess) | achieves(Research, Breakthrough))",
        "natural": "The platform achieves commercial success or the research achieves a breakthrough"
      },
      "(A19 → ¬A18)": {
        "formal": "(A19 → ¬A18)",
        "prover9": "(A19 -> -A18)",
        "prover9_expression": "(faces(Platform, MarketCompetition) -> -achieves(Platform, CommercialSuccess))",
        "natural": "If the platform faces market competition, then the platform does not achieve commercial success"
      },
      "(A2 → G)": {
        "formal": "(A2 → G)",
        "prover9": "(A2 -> G)",
        "prover9_expression": "(receives_funding(Facility, CorporateGrant) -> achieves(Research, Breakthrough))",
        "natural": "If the research facility receives corporate grant funding, then the research achieves a breakthrough"
      },
      "(A20 → A19)": {
        "formal": "(A20 → A19)",
        "prover9": "(A20 -> A19)",
        "prover9_expression": "(invests(Company, MarketingCampaign) -> faces(Platform, MarketCompetition))",
        "natural": "If the company invests in a marketing campaign, then the platform faces market competition"
      },
      "(A22 → (¬A20 → A21))": {
        "formal": "(A22 → (¬A20 → A21))",
        "prover9": "(A22 -> (-A20 -> A21))",
        "prover9_expression": "(implements(Company, PriceReduction) -> (-invests(Company, MarketingCampaign) -> gains(Platform, MarketShare)))",
        "natural": "If the company implements a price reduction, then provided that the company does not invest in a marketing campaign, the platform gains market share"
      },
      "(A22 ∨ A23)": {
        "formal": "(A22 ∨ A23)",
        "prover9": "(A22 | A23)",
        "prover9_expression": "(implements(Company, PriceReduction) | launches(Company, PromotionalOffer))",
        "natural": "The company implements a price reduction or the company launches a promotional offer"
      },
      "(A23 → (¬A20 → A21))": {
        "formal": "(A23 → (¬A20 → A21))",
        "prover9": "(A23 -> (-A20 -> A21))",
        "prover9_expression": "(launches(Company, PromotionalOffer) -> (-invests(Company, MarketingCampaign) -> gains(Platform, MarketShare)))",
        "natural": "If the company launches a promotional offer, then under the condition that the company does not invest in a marketing campaign, the platform gains market share"
      },
      "(A24 → (A22 → (¬A20 → A21)))": {
        "formal": "(A24 → (A22 → (¬A20 → A21)))",
        "prover9": "(A24 -> (A22 -> (-A20 -> A21)))",
        "prover9_expression": "(analyzes(Company, MarketData) -> (implements(Company, PriceReduction) -> (-invests(Company, MarketingCampaign) -> gains(Platform, MarketShare))))",
        "natural": "If the company analyzes market data, then should the company implement a price reduction, given that the company does not invest in a marketing campaign, the platform gains market share"
      },
      "(A24 ∨ A25)": {
        "formal": "(A24 ∨ A25)",
        "prover9": "(A24 | A25)",
        "prover9_expression": "(analyzes(Company, MarketData) | conducts(Company, ConsumerSurvey))",
        "natural": "The company analyzes market data or the company conducts a consumer survey"
      },
      "(A25 → (A22 → (¬A20 → A21)))": {
        "formal": "(A25 → (A22 → (¬A20 → A21)))",
        "prover9": "(A25 -> (A22 -> (-A20 -> A21)))",
        "prover9_expression": "(conducts(Company, ConsumerSurvey) -> (implements(Company, PriceReduction) -> (-invests(Company, MarketingCampaign) -> gains(Platform, MarketShare))))",
        "natural": "If the company conducts a consumer survey, then whenever the company implements a price reduction and the company does not invest in a marketing campaign, the platform gains market share"
      },
      "(A26 → A27)": {
        "formal": "(A26 → A27)",
        "prover9": "(A26 -> A27)",
        "prover9_expression": "(contains(Material, Alcohol) -> requires(Material, SpecialStorage))",
        "natural": "If the material contains alcohol, then the material requires special storage"
      },
      "(A26 ∨ G)": {
        "formal": "(A26 ∨ G)",
        "prover9": "(A26 | G)",
        "prover9_expression": "(contains(Material, Alcohol) | achieves(Research, Breakthrough))",
        "natural": "The material contains alcohol or the research achieves a breakthrough"
      },
      "(A28 ∨ ¬A27)": {
        "formal": "(A28 ∨ ¬A27)",
        "prover9": "(A28 | -A27)",
        "prover9_expression": "(degrades(Material, RoomTemperature) | -requires(Material, SpecialStorage))",
        "natural": "The material degrades at room temperature or the material does not require special storage"
      },
      "(A3 → A1)": {
        "formal": "(A3 → A1)",
        "prover9": "(A3 -> A1)",
        "prover9_expression": "(conducts_research(Facility, PlantExtract) -> receives_funding(Facility, GovernmentGrant))",
        "natural": "If the research facility conducts research on plant extracts, then the research facility receives government grant funding"
      },
      "(A3 ∨ A4)": {
        "formal": "(A3 ∨ A4)",
        "prover9": "(A3 | A4)",
        "prover9_expression": "(conducts_research(Facility, PlantExtract) | conducts_research(Facility, SyntheticCompound))",
        "natural": "The research facility conducts research on plant extracts or the research facility conducts research on synthetic compounds"
      },
      "(A30 → A29)": {
        "formal": "(A30 → A29)",
        "prover9": "(A30 -> A29)",
        "prover9_expression": "(files(Organization, PatentExtension) -> extends(Organization, PatentProtection))",
        "natural": "If the organization files a patent extension, then the organization extends patent protection"
      },
      "(A4 → A2)": {
        "formal": "(A4 → A2)",
        "prover9": "(A4 -> A2)",
        "prover9_expression": "(conducts_research(Facility, SyntheticCompound) -> receives_funding(Facility, CorporateGrant))",
        "natural": "If the research facility conducts research on synthetic compounds, then the research facility receives corporate grant funding"
      },
      "(A5 → A6)": {
        "formal": "(A5 → A6)",
        "prover9": "(A5 -> A6)",
        "prover9_expression": "(synthesizes(Facility, PlantExtract, DrugCompound) -> progresses(Research, PlantExtract))",
        "natural": "If the research facility synthesizes plant extracts into drug compounds, then research on plant extracts progresses"
      },
      "(A5 → ¬A6)": {
        "formal": "(A5 → ¬A6)",
        "prover9": "(A5 -> -A6)",
        "prover9_expression": "(synthesizes(Facility, PlantExtract, DrugCompound) -> -progresses(Research, PlantExtract))",
        "natural": "If the research facility synthesizes plant extracts into drug compounds, then research on plant extracts does not progress"
      },
      "(A5 ∨ (A3 ∨ A4))": {
        "formal": "(A5 ∨ (A3 ∨ A4))",
        "prover9": "(A5 | (A3 | A4))",
        "prover9_expression": "(synthesizes(Facility, PlantExtract, DrugCompound) | (conducts_research(Facility, PlantExtract) | conducts_research(Facility, SyntheticCompound)))",
        "natural": "The research facility synthesizes plant extracts into drug compounds or the research facility conducts research on plant extracts or the research facility conducts research on synthetic compounds"
      },
      "(A8 → G)": {
        "formal": "(A8 → G)",
        "prover9": "(A8 -> G)",
        "prover9_expression": "(publishes(Organization, ResearchPaper) -> achieves(Research, Breakthrough))",
        "natural": "If the organization publishes a research paper, then the research achieves a breakthrough"
      },
      "(A8 ∨ A9)": {
        "formal": "(A8 ∨ A9)",
        "prover9": "(A8 | A9)",
        "prover9_expression": "(publishes(Organization, ResearchPaper) | presents(Organization, ConferenceFindings))",
        "natural": "The organization publishes a research paper or the organization presents conference findings"
      },
      "(A9 → G)": {
        "formal": "(A9 → G)",
        "prover9": "(A9 -> G)",
        "prover9_expression": "(presents(Organization, ConferenceFindings) -> achieves(Research, Breakthrough))",
        "natural": "If the organization presents conference findings, then the research achieves a breakthrough"
      },
      "(¬(A13 ∨ G) → A14)": {
        "formal": "(¬(A13 ∨ G) → A14)",
        "prover9": "(-(A13 | G) -> A14)",
        "prover9_expression": "(-(receives(Platform, RegulatoryApproval) | achieves(Research, Breakthrough)) -> develops(Organization, AlternativeCompound))",
        "natural": "If neither the platform receives regulatory approval nor the research achieves a breakthrough, then the organization develops an alternative compound"
      },
      "(¬(A30 → A29) → A31)": {
        "formal": "(¬(A30 → A29) → A31)",
        "prover9": "(-(A30 -> A29) -> A31)",
        "prover9_expression": "(-(files(Organization, PatentExtension) -> extends(Organization, PatentProtection)) -> challenged(Patent, GenericManufacturers))",
        "natural": "If it is not the case that filing a patent extension by the organization leads to extended patent protection, then the patent is challenged by generic manufacturers"
      },
      "(¬(A30 → A29) → ¬A31)": {
        "formal": "(¬(A30 → A29) → ¬A31)",
        "prover9": "(-(A30 -> A29) -> -A31)",
        "prover9_expression": "(-(files(Organization, PatentExtension) -> extends(Organization, PatentProtection)) -> -challenged(Patent, GenericManufacturers))",
        "natural": "If it is not the case that filing a patent extension by the organization leads to extended patent protection, then the patent is not challenged by generic manufacturers"
      },
      "(¬(A5 → A6) → A7)": {
        "formal": "(¬(A5 → A6) → A7)",
        "prover9": "(-(A5 -> A6) -> A7)",
        "prover9_expression": "(-(synthesizes(Facility, PlantExtract, DrugCompound) -> progresses(Research, PlantExtract)) -> designed(ManufacturingProcess, PlantExtract))",
        "natural": "If synthesizing plant extracts into drug compounds by the research facility does not result in progress of research on plant extracts, then a manufacturing process for plant extracts is designed"
      },
      "(¬(A5 → A6) → ¬A7)": {
        "formal": "(¬(A5 → A6) → ¬A7)",
        "prover9": "(-(A5 -> A6) -> -A7)",
        "prover9_expression": "(-(synthesizes(Facility, PlantExtract, DrugCompound) -> progresses(Research, PlantExtract)) -> -designed(ManufacturingProcess, PlantExtract))",
        "natural": "If synthesizing plant extracts into drug compounds by the research facility does not result in progress of research on plant extracts, then a manufacturing process for plant extracts is not designed"
      },
      "(¬(A9 → G) → A10)": {
        "formal": "(¬(A9 → G) → A10)",
        "prover9": "(-(A9 -> G) -> A10)",
        "prover9_expression": "(-(presents(Organization, ConferenceFindings) -> achieves(Research, Breakthrough)) -> approved(ClinicalTrial, RegulatoryBody))",
        "natural": "If presenting conference findings by the organization does not lead to research breakthrough, then the clinical trial receives regulatory body approval"
      },
      "(¬(A9 → G) → A11)": {
        "formal": "(¬(A9 → G) → A11)",
        "prover9": "(-(A9 -> G) -> A11)",
        "prover9_expression": "(-(presents(Organization, ConferenceFindings) -> achieves(Research, Breakthrough)) -> submits(Organization, ClinicalTrialApplication))",
        "natural": "If presenting conference findings by the organization does not lead to research breakthrough, then the organization submits a clinical trial application"
      },
      "(¬(¬(A9 → G) → A10) → A29)": {
        "formal": "(¬(¬(A9 → G) → A10) → A29)",
        "prover9": "(-(-(A9 -> G) -> A10) -> A29)",
        "prover9_expression": "(-(-(presents(Organization, ConferenceFindings) -> achieves(Research, Breakthrough)) -> approved(ClinicalTrial, RegulatoryBody)) -> extends(Organization, PatentProtection))",
        "natural": "If the failure of presenting conference findings to lead to research breakthrough does not result in clinical trial approval by the regulatory body, then the organization extends patent protection"
      },
      "(¬(¬(A9 → G) → A10) → A30)": {
        "formal": "(¬(¬(A9 → G) → A10) → A30)",
        "prover9": "(-(-(A9 -> G) -> A10) -> A30)",
        "prover9_expression": "(-(-(presents(Organization, ConferenceFindings) -> achieves(Research, Breakthrough)) -> approved(ClinicalTrial, RegulatoryBody)) -> files(Organization, PatentExtension))",
        "natural": "If the failure of presenting conference findings to lead to research breakthrough does not result in clinical trial approval by the regulatory body, then the organization files a patent extension"
      },
      "(¬(¬(A9 → G) → A10) → ¬A29)": {
        "formal": "(¬(¬(A9 → G) → A10) → ¬A29)",
        "prover9": "(-(-(A9 -> G) -> A10) -> -A29)",
        "prover9_expression": "(-(-(presents(Organization, ConferenceFindings) -> achieves(Research, Breakthrough)) -> approved(ClinicalTrial, RegulatoryBody)) -> -extends(Organization, PatentProtection))",
        "natural": "If the failure of presenting conference findings to lead to research breakthrough does not result in clinical trial approval by the regulatory body, then the organization does not extend patent protection"
      },
      "(¬A20 → A21)": {
        "formal": "(¬A20 → A21)",
        "prover9": "(-A20 -> A21)",
        "prover9_expression": "(-invests(Company, MarketingCampaign) -> gains(Platform, MarketShare))",
        "natural": "If the company does not invest in a marketing campaign, then the platform gains market share"
      },
      "A19": {
        "formal": "A19",
        "prover9": "A19",
        "prover9_expression": "faces(Platform, MarketCompetition)",
        "natural": "The platform faces market competition"
      },
      "A20": {
        "formal": "A20",
        "prover9": "A20",
        "prover9_expression": "invests(Company, MarketingCampaign)",
        "natural": "The company invests in a marketing campaign"
      },
      "G": {
        "formal": "G",
        "prover9": "G",
        "prover9_expression": "achieves(Research, Breakthrough)",
        "natural": "The research achieves a breakthrough"
      },
      "¬A10": {
        "formal": "¬A10",
        "prover9": "-A10",
        "prover9_expression": "-approved(ClinicalTrial, RegulatoryBody)",
        "natural": "The clinical trial does not receive regulatory body approval"
      },
      "¬A13": {
        "formal": "¬A13",
        "prover9": "-A13",
        "prover9_expression": "-receives(Platform, RegulatoryApproval)",
        "natural": "The platform does not receive regulatory approval"
      },
      "¬A14": {
        "formal": "¬A14",
        "prover9": "-A14",
        "prover9_expression": "-develops(Organization, AlternativeCompound)",
        "natural": "The organization does not develop an alternative compound"
      },
      "¬A15": {
        "formal": "¬A15",
        "prover9": "-A15",
        "prover9_expression": "-identifies(Researchers, SideEffects)",
        "natural": "Researchers do not identify side effects"
      },
      "¬A18": {
        "formal": "¬A18",
        "prover9": "-A18",
        "prover9_expression": "-achieves(Platform, CommercialSuccess)",
        "natural": "The platform does not achieve commercial success"
      },
      "¬A21": {
        "formal": "¬A21",
        "prover9": "-A21",
        "prover9_expression": "-gains(Platform, MarketShare)",
        "natural": "The platform does not gain market share"
      },
      "¬A26": {
        "formal": "¬A26",
        "prover9": "-A26",
        "prover9_expression": "-contains(Material, Alcohol)",
        "natural": "The material does not contain alcohol"
      },
      "¬A27": {
        "formal": "¬A27",
        "prover9": "-A27",
        "prover9_expression": "-requires(Material, SpecialStorage)",
        "natural": "The material does not require special storage"
      },
      "¬A28": {
        "formal": "¬A28",
        "prover9": "-A28",
        "prover9_expression": "-degrades(Material, RoomTemperature)",
        "natural": "The material does not degrade at room temperature"
      },
      "¬A5": {
        "formal": "¬A5",
        "prover9": "-A5",
        "prover9_expression": "-synthesizes(Facility, PlantExtract, DrugCompound)",
        "natural": "The research facility does not synthesize plant extracts into drug compounds"
      }
    }
  }
}